Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Department of Surgery, University of California Los Angeles, Los Angeles, California.
Kidney360. 2021 Jun 15;2(8):1380-1389. doi: 10.34067/KID.0002882021. eCollection 2021 Aug 26.
Vascular access planning is critical in the management of patients with advanced kidney disease who elect for hemodialysis for RRT. Policies put in place more than two decades ago attempted to standardize vascular access care around the model of optimal, namely arteriovenous fistula, and least preferred, namely central venous catheter, type of access. This homogenized approach to vascular access care emerged ineffective in the increasingly heterogeneous and complex dialysis population. The most recent vascular access guidelines acknowledge the limitations of standardized care and encourage tailoring vascular access care on the basis of patient and disease characteristics. In this article, we discuss available literature in support of patient-tailored access care on the basis of differences in vascular access outcomes by biologic and social factors-age, sex, and race. Further, we draw attention to the overlooked dimension of patient-reported preferences and shared decision making in the practice of vascular access planning. We discuss milestones to overcome as requisite steps to implement effective shared decision making in vascular access care. Finally, we take into consideration local practice cofactors as major players in vascular access fate. We conclude that a personalized approach to hemodialysis vascular access will require dynamic care specifically relevant to the individual on the basis of biologic factors, fluctuating clinical needs, values, and preferences.
血管通路规划在管理选择血液透析作为肾脏替代治疗的晚期肾病患者中至关重要。二十多年前制定的政策试图围绕最佳(即动静脉瘘)和最不受欢迎(即中心静脉导管)的血管通路类型,标准化血管通路护理。这种同质化的血管通路护理方法在日益多样化和复杂的透析人群中效果不佳。最近的血管通路指南认识到标准化护理的局限性,并鼓励根据患者和疾病特征定制血管通路护理。在本文中,我们根据生物和社会因素(年龄、性别和种族)对血管通路结局的差异,讨论支持个体化患者通路护理的可用文献。此外,我们提请注意在血管通路规划实践中,患者报告的偏好和共同决策被忽视的维度。我们讨论了克服的里程碑,作为在血管通路护理中实施有效共同决策的必要步骤。最后,我们考虑到当地实践的共同因素是血管通路命运的主要参与者。我们得出结论,个性化的血液透析血管通路方法将需要根据生物因素、不断变化的临床需求、价值观和偏好,为个体提供具体的动态护理。